The Exchange has received the disclosure under Regulation 29(1) / 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Riddhish Natwarlal Tanna
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Riddhish Natwarlal Tanna, a promoter of Aptus Pharma Ltd, acquired 18,000 equity shares (0.26% of total share capital) on 11 May 2026. Prior to this purchase, his holding was 5,75,000 shares (8.38%). After the acquisition, his total holding increased to 5,93,000 shares (8.64%). The mode of acquisition appears to be an inter-se transfer within the promoter group. There are no encumbrances (pledges/liens) reported on the shares. The total share capital of the company remains unchanged at 68,60,000 equity shares of Rs. 10 each.
This is a small incremental purchase by an existing promoter and is unlikely to have any material impact on the stock price. The promoter remains a minority shareholder at 8.64%, well below any takeover threshold.